A U.K. woman, who was diagnosed with a rare cancer, recalls having eight organs removed in what she described as 'the mother ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

SHRA-1921 is under clinical development by Jiangsu Hengrui Medicine and currently in Phase II for Metastatic Breast Cancer.

The technology, known also as AI , can correctly spot tiny tumours, called lesions, on ultrasound images of the ovaries, ...

Since its discovery in the 1990s, "programmed cell death protein 1," or PD-1, has been regarded as a leading target in cancer treatments.

In the lead-up to Sheila Hailstone’s cancer diagnosis, months before she even noticed a breast lump herself, her dog,. One ...

Despite recent therapeutic breakthroughs, cancer patients continue to face high recurrence and mortality rates due to treatment resistance. Cancer stem cells (CSCs), a subpopulation with self-renewal ...

Potential practice-changing therapies in gynecologic cancer include the emergence of carboplatin, paclitaxel, and PD-1 ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

In an extremely rare case, a doctor operating on a cancer patient in Germany accidentally 'transplanted' the disease into ...

RECORD numbers of cancers are being diagnosed early when they are more curable, NHS figures show. Nearly six in ten of the 13 ...